Ivermectin trial halted due to bogus “supply issues”. By Meiling Lee.

Ivermectin is being investigated as part of the government-backed Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE) in the United Kingdom as a possible home treatment for COVID-19 …

The trial was put on hold due to “temporary supply issues” as reported by Medpage Today on Dec. 14.

Details were not provided on the cause of the supply issues. The trial’s joint chief investigator, professor Chris Butler, and the trial’s press team declined to comment and respond to a query asking when the supply issue is expected to be resolved. …

Dr. Tess Lawrie, director of the Evidence-based Medicine Consultancy, said the supply issue cited was “plainly ridiculous.” … “We are talking about a most abundant off-patent medicine that is produced in many countries around the world. There are many European manufacturers too, including Huvepharma in Bulgaria.”

Chief of the Division of Pulmonary and Critical Care Medicine at the Eastern Virginia Medical School Dr. Paul Marik said the reason given by PRINCIPLE was “nonsense.”

“It’s clear this is an ominous plot. A supply issue with IVERMECTIN; you must be kidding,” Marik told The Epoch Times in an email. “After 3.7 BILLION doses have been dispensed in the last 2 decades; we have a supply issue; what nonsense.” …

Dr. Robert Malone, the inventor of the messenger RNA vaccine technology, says … “Either they’re grossly incompetent at the University of Oxford or lying. It’s one or the other because [the] worldwide supply of ivermectin is enormous, and there’s no way that a competent clinical research team would not have locked down their trial supply.”